(Q54068992)

English

Comparative effects of omeprazole, amoxycillin plus metronidazole versus omeprazole, clarithromycin plus metronidazole on the oral, gastric and intestinal microflora in Helicobacter pylori-infected patients.

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/10552979

Comparative effects of omeprazole, amoxycillin plus metronidazole versus omeprazole, clarithromycin plus metronidazole on the oral, gastric and intestinal microflora in Helicobacter pylori-infected patients. (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/10552979

Helicobacter pylori

0 references

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Adamsson I

1

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/10552979

Nord CE

2

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/10552979

Lundquist P

3

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/10552979

Sjöstedt S

4

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/10552979

Edlund C

5

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/10552979

language of work or name

0 references

publication date

1 November 1999

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/10552979

number of pages

12

1 reference

based on heuristic

inferred from page(s)

Journal of Antimicrobial Chemotherapy

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/10552979

44

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/10552979

5

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/10552979

629-640

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/10552979

Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials: the MACH I Study

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2F44.5.629

21 January 2018

Effect of Phenoxymethylpenicillin and Clindamycin on the Oral, Throat and Faecal Microflora of Man

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2F44.5.629

21 January 2018

Impact of antimicrobial agents on human intestinal microflora

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2F44.5.629

21 January 2018

Helicobacter pylori and gastric diseases

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2F44.5.629

21 January 2018

Prolonged and profound acid inhibition is crucial in Helicobacter pylori treatment with a proton pump inhibitor combined with amoxicillin

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2F44.5.629

21 January 2018

The role of antisecretory drugs in the treatment of Helicobacter pylori infection

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2F44.5.629

21 January 2018

The relationship between an increase in beta-lactamase activity after oral administration of three new cephalosporins and protection against intestinal ecological disturbances.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2F44.5.629

21 January 2018

Anaerobic infections in humans: an overview

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2F44.5.629

21 January 2018

Microbiological aspects of Helicobacter pylori (Campylobacter pylori).

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2F44.5.629

21 January 2018

Identifiers

10.1093/JAC/44.5.629

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/10552979

release_asnds4dc3rfi3k6o2ji6bwsecq

1 reference

https://api.fatcat.wiki/v0/release/asnds4dc3rfi3k6o2ji6bwsecq

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/10552979

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54068992&oldid=1842672874"